Search | Dengue Academy

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

This website is intended for informational purposes only and is not a substitute for healthcare professional’s clinical knowledge or professional judgment.

© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023

Latest Research on Dengue Science

Takeda
Insecticide resistance in dengue vectors from hotspots in Selangor, Malaysia

Takeda

2 minutes
Similarities and differences between 'cytokine storms’ in acute dengue and COVID-19

Takeda

2 minutes
Dengue: Not Just 1 Virus, Not Just 1 Infection

Medscape

15 minutes
Antibody Levels over Time

Takeda

2 minutes
Immune response to dengue virus

Takeda

4 minutes
Dengue virus and pathobiology

Takeda

1 minutes
NS1 and its potential association with severe dengue

Takeda

3 minutes
Dengue - unanswered scientific questions

Takeda

11 minutes
Dengue serotypes

Takeda

4 minutes
Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes

Takeda

2 minutes
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection

Takeda

2 minutes
Coagulation abnormalities in Dengue fever infection: A systematic review and meta-analysis

Takeda

2 minutes
Distinct Dengue Epidemiology and Viral Characteristics in Indonesia

ADVA

25 minutes
Dengue Virus Life Cycle

HHMI BioInteractive

4 minutes
Dengue disease awareness

ISID

39 minutes
Case presentations in severe dengue: contemporary approaches to clinical management

Medscape

45 minutes
Managing the severely ill dengue patients – Adult and Paediatric Intensivists

ADVA

92 minutes
Effects of dengue

Takeda

7 minutes
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study

Takeda

2 minutes

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

This website is intended for informational purposes only and is not a substitute for healthcare professional’s clinical knowledge or professional judgment.